Volume 26 continues the trend of shorter, more frequent volumes. With Volume 25, the series gained a new co-editor, Urs Meyer. While retaining the commitment to publish chapters on therapeutic or chemical classes and on general topics or concepts, the series' coverage has expanded to include methodological chapters, and new areas of recognized or potential significance to drug research, especially in molecular pharmacology.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Better World Books, Mishawaka, IN, Etats-Unis
Etat : Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. N° de réf. du vendeur 58069623-6
Quantité disponible : 1 disponible(s)
Vendeur : The Book Exchange, Macclesfield, CHESH, Royaume-Uni
Hardcover. Etat : Near Fine. No Jacket. 0120133261. A near fine ex lib. hardcover. 279 pages, subject and author index, cumulative index of Titles, illustrated with charts, tables and diagrams. Sections include . Kier, L.B. and Testa, B, Complexity and Emergence in Drug Research. M.S. Tute, Drug Design: the Present and the Future. K. Burki and B. Ledermann, Transgenic Animals as Pharmacological Tools. C.L. Crespi, Xenobiotic-metabolizing Human Cells as Tools for Pharmacological and Toxicological Research. J. Urquhart, Correlates of Variable Patient Compliance in Drug Trials: Relevance in the New Health Care Environment. Contents as new, clean, tight and bright. Book. N° de réf. du vendeur 026460
Quantité disponible : 1 disponible(s)